Access the latest resources selected for you by clicking each tab below.
For the full list, visit the Resource Library.
Basic research is the foundation of all scientific breakthroughs, improving our understanding of biology and advancing our knowledge of the life sciences. Learn more about our animal models and CRISPR technology.
Though rewarding, drug discovery can be a challenging journey. Too often, a novel compound’s road to market is delayed – or blocked entirely – by limited resources or expertise. Learn how to mitigate those delays through our approach to target discovery, hit finding, lead optimization, and beyond.
Determination of a drug’s safety profile is perhaps one of the most critical stages of the drug development pathway. Complications and inefficiencies at this late phase of the journey can create costly delays. See the latest resources to help you overcome these common issues.
|eGuide: Investigational New Drug (IND) Development Programs|
|eGuide: Standard for Exchange of Nonclinical Data (SEND)|
|Posters: Society of Toxicology (SOT) Resource Center – Access our 40 ePosters|
|Webinar | March 25, 2020: Interchangeability of Southeast Asian Sourced Large Animals and Managing Supply|
|Webinar | April 8, 2020: Mastering qPCR for Biodistribution and Shedding Studies of Cell & Gene Therapies|
|Webinar, On Demand: Succeeding with New SEND Requirements: Expert Panel Discussion|
|Webinar, On Demand: Unpacking the ERA Guideline Revisions|
|Webinar Series: Are You Ready for the Digital Pathology Revolution?|
Laboratory sciences is an integral part of drug development, from the earliest stages of nonclinical work, requiring the efficient development and transfer of methods, to produce detailed, on-time data to support decision making. Access the latest resources to stay up-to-date on ADME, metabolites, and the microbiome.
The approval process for ensuring the identity, potency, purity, safety, and effectiveness of a biopharmaceutical is complex. Navigating this process effectively is critical to the ultimate commercial success of a product. Find out more about building your biologic, viral clearance, next generation sequencing and more with our array of digital resources.
|eGuide: Building a Biologic|
|Poster: A Comparative Analysis of Viral Clearance by Affinity and AEX Chromatography|
|Webinar | March 26, 2020: Choosing the Right Virus for Your Viral Clearance Studies|
|Webinar, On Demand: Analytical Techniques for Identification and Quantification of Process Residuals|
|Webinar, On Demand: Applying Next Generation Sequencing to Biologics Testing: What You Really Need to Know|
|Webinar, On Demand: Determining the Optimal Pyrogenicity Testing Approach for Your Product|
|Webinar, On Demand: Development, Validation, and Implementation of GMP Release Potency Assays for Vaccines|
|Webinar, On Demand: Endotoxin Testing Limits, Method Development and Validation for Plasma-Derived Products|
|Webinar, On Demand: LER: A Biopharmaceutical Operational Reality Perspective|
|Webinar, On Demand: New Strategies for Quality Control of Host Cell Protein Impurities|
Testing for microbial contaminants is necessary to ensure the safety and quality of their products, but the process can add costly delays in their release to market. Learn how to streamline testing and mitigate these risks with revolutionary technologies and exceptional services that have changed the way the industries conduct quality control.